Of note, EZH2 levels were low in clinically aggressive subset #2, thus sharply contrasting aggressive, U-CLL stereotyped subsets #1, #6 and #8 (Figure 1B). Here, EZH2 is linked to B-cell chronic lymphocytic leukemia.